AEGiS-WSJ: Health: Johnson & Johnson Pulls Its Home Test For HIV Off Market Wall Street JournalImportant note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Click here to return to Wall Street Journal main menu




DonateNow



Health: Johnson & Johnson Pulls Its Home Test For HIV Off Market

The Wall Street Journal - Friday, 27 June 1997


NEW BRUNSWICK, N.J. -- Johnson & Johnson's Direct Access Diagnostics unit said it is immediately taking its Confide HIV home test off the market due to a lack of demand.

"We thought consumer demand would be greater than it was. We were on the market for about a year, and in that time did about 90,000 tests," said a spokesman for Johnson & Johnson, a personal-care and hygienic-products maker. The company wouldn't say how many tests it had expected to sell.

The only other competitor in the market now is Home Access Health Corp., Hoffman Estates, Ill., which first began selling its product last August.

"Clearly, consumers have been voting with their pocketbooks," said Richard A. Quattrocchi, president of closely held Home Access Health. He said Home Access has sold about 150,000 tests so far this year.

Confide, which was approved for sale by the Food and Drug Administration in May 1996, went on the market nationally in September 1996.

Direct Access said it stopped shipping Confide yesterday and is asking retail and wholesale customers to remove shelf stocks immediately and return all inventories. The tests, which consumers mail back to the company for results, will continue to be processed until Aug. 8. Any customer submitting test results after this date will be informed of steps to take for a refund.

The Confide Result Center will continue to operate until Aug. 29, in order to transmit results and provide counseling and referral services. Anyone calling after this date will be referred to the National AIDS Hotline.


Keywords: HIV

KWDhiv
970627
WJ970605


Copyright © 1997 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .